Multidrug-resistant Gram-negative bacterial infections are exponentially increasing, posing
one of the most urgent global healthcare and economic threats. Due to the lack of new …

Antibiotic resistance (AR) is a silent pandemic that kills millions worldwide. Although the
development of new therapeutic agents against antibiotic resistance is in urgent demand …

Bacterial pathogens resistant to multiple structurally distinct antimicrobial agents are
causative agents of infectious disease, and they thus constitute a serious concern for public …

The interplay between antibiotic resistance and bacterial fitness/virulence has attracted the
interest of researchers for decades because of its therapeutic implications, since it is …

Pseudomonas aeruginosa (P. aeruginosa) poses a grave clinical challenge due to its
multidrug resistance (MDR) phenotype, leading to severe and life-threatening infections …

Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for multiple
hospital-and community-acquired infections, both in human and veterinary medicine. P …

Antibiotic resistance is a pressing public health threat. Despite rising resistance, antibiotic
development, especially for Gram-negative bacteria, has stagnated. As the traditional …

Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium renowned for its
resilience and adaptability across diverse environments, including clinical settings, where it …

Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for infections in
people living with chronic respiratory conditions, such as cystic fibrosis (CF) and non-CF …

With the rising incidences of antimicrobial resistance (AMR) and the diminishing options of
novel antimicrobial agents, it is paramount to decipher the molecular mechanisms of action …